APA

Brocker C. N., Velenosi T., Flaten H. K., McWilliams G., McDaniel K., Shelton S. K., Saben J., Krausz K. W., Gonzalez F. J. & Monte A. A. (20210706). Metabolomic profiling of metoprolol hypertension treatment reveals altered gut microbiota-derived urinary metabolites. : Human genomics.

Chicago

Brocker Chad N, Velenosi Thomas, Flaten Hania K, McWilliams Glenn, McDaniel Kyle, Shelton Shelby K, Saben Jessica, Krausz Kristopher W, Gonzalez Frank J and Monte Andrew A. 20210706. Metabolomic profiling of metoprolol hypertension treatment reveals altered gut microbiota-derived urinary metabolites. : Human genomics.

Harvard

Brocker C. N., Velenosi T., Flaten H. K., McWilliams G., McDaniel K., Shelton S. K., Saben J., Krausz K. W., Gonzalez F. J. and Monte A. A. (20210706). Metabolomic profiling of metoprolol hypertension treatment reveals altered gut microbiota-derived urinary metabolites. : Human genomics.

MLA

Brocker Chad N, Velenosi Thomas, Flaten Hania K, McWilliams Glenn, McDaniel Kyle, Shelton Shelby K, Saben Jessica, Krausz Kristopher W, Gonzalez Frank J and Monte Andrew A. Metabolomic profiling of metoprolol hypertension treatment reveals altered gut microbiota-derived urinary metabolites. : Human genomics. 20210706.